Statement by the Board of Directors of Nuevolution in Relation to the Public Offer From Amgen

STOCKHOLM, May 22, 2019 /PRNewswire/ — This statement is made by the Board of Directors[1] of Nuevolution AB (publ) (the “Company” or “Nuevolution”) pursuant to Rule II.19 of the Nasdaq Stockholm Takeover Rules (the “Takeover Rules”). Comment from Stig Løkke Pedersen, Chairman of the…

Source: https://www.prnewswire.com:443/news-releases/statement-by-the-board-of-directors-of-nuevolution-in-relation-to-the-public-offer-from-amgen-300854857.html